Enovis to Host Fourth Quarter and Full Year 2022 Conference Call on February 23rd

Rhea-AI Summary

Enovis Corporation (NYSE: ENOV), a medical technology growth company, has announced an investor conference call and live webcast to discuss its Q4 and full year 2022 financial results. This event is scheduled for February 23, 2023, at 8:30 AM ET, with an earnings press release set to be issued earlier that same morning. Investors can access the webcast through the Enovis website, and a replay will also be available later. Enovis is committed to developing innovative solutions that improve patient outcomes, focusing on orthopedics and related sectors.

Wilmington, DE, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2022 financial results on Thursday, February 23, 2023 at 8:30AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.

Conference call/Webcast Information

Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 630-1956 (U.S. callers) and (412) 317-1837 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-421-1971
investorrelations@enovis.com

Source: Enovis Corporation

FAQ

When will Enovis announce its Q4 2022 financial results?

Enovis will announce its Q4 2022 financial results during an investor conference call on February 23, 2023, at 8:30 AM ET.

How can I access the Enovis investor conference call?

Investors can access the Enovis investor conference call by dialing (833) 630-1956 for U.S. callers and (412) 317-1837 for international callers.

Will there be a replay of the Enovis conference call?

Yes, a replay of the Enovis conference call will be available on the Enovis website later on February 23, 2023.

Where can I find the earnings press release from Enovis?

The earnings press release from Enovis will be issued on February 23, 2023, and can be found in the Investors section on their website.

What is the focus of Enovis Corporation?

Enovis Corporation focuses on developing innovative medical technologies, particularly in orthopedics, to achieve better patient outcomes and improve workflows.